Rx drug information, pharmaceutical research, clinical trials, news, and more
A phase II, randomized, placebo-controlled study of vismodegib as maintenance therapy in patients with ovarian cancer in second or third complete remission. [2012]
Inhibiting the hedgehog pathway in patients with the basal-cell nevus syndrome. [2012]
A randomized phase II trial of vismodegib versus placebo with FOLFOX or FOLFIRI and bevacizumab in patients with previously untreated metastatic colorectal cancer. [2013]
Pharmacokinetic dose-scheduling study of hedgehog pathway inhibitor vismodegib (GDC-0449) in patients with locally advanced or metastatic solid tumors. [2011]
Hedgehog antagonist GDC-0449 is effective in the treatment of advanced basal cell carcinoma. [2010]
Systemic therapy for inoperable and metastatic basal cell cancer. [2013]
All Rights reserved - Copyright DrugLib.com, 2006-2017